TABLE 74-2 Definition of TNM-Nasopharynx
TABLE 74-2 Definition of TNM-Nasopharynx |
|||||
Primary Tumor (T) |
Stage Grouping |
||||
TX |
Cannot be assessed |
Stage 0 |
Tis |
N0 |
M0 |
T0 |
No evidence |
Stage I |
T1 |
N0 |
M0 |
Tis |
Carcinoma in situ |
Stage IIA |
T2a |
N0 |
M0 |
T1 |
Tumor confined to the nasopharynx |
Stage IIB |
T1 |
N1 |
M0 |
T2 |
Tumor extends to soft tissues |
T2 |
N1 |
M0 |
|
T2a Tumor extends to the oropharynx and/or nasal cavity w/o parapharyngeal extension |
T2a |
N1 |
M0 |
||
T2b Any tumor with parapharyngeal extension |
T2b |
N1 |
M0 |
||
T3 |
Tumor involves bony structures and/or paranasal sinuses |
T2b |
N1 |
M0 |
|
T4 |
Tumor with intracranial extension and/or involvement of cranial nerves, infratemporal fossa, hypopharynx, orbit, or masticator space |
Stage III |
T1 T2a |
N2 N2 |
M0 M0 |
Regional Lymph Nodes (N) |
T2b |
N2 |
M0 |
||
The distribution and the prognostic impact of regional lymph node spread from nasopharynx cancer, particularly of the undifferentiated type, are different from those of other head and neck mucosal cancers and justify the use of a different N classification scheme. |
T3 |
N0 |
M0 |
||
NX Regional lymph nodes cannot be assessed |
T3 |
N1 |
M0 |
||
N0 No regional lymph node metastasis |
T3 |
N2 |
M0 |
||
N1 Unilateral metastasis in lymph node(s), ≤6 cm in greatest dimension, above the supraclavicular fossa |
T4 |
N0 |
M0 |
||
N2 Bilateral metastasis in lymph node(s), ≤6 cm in greatest dimension, above the supraclavicular fossa |
T4 |
N1 |
M0 |
||
N3 Metastasis in lymph node(s), >6 cm and/or to supraclavicular fossa |
T4 |
N2 |
M0 |
||
N3a Greater than 6 cm in dimension |
Any T |
N3 |
M0 |
||
N3b Extension to the supraclavicular fossa |
Any T |
Any N |
M1 |
||